This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ALFRED W. SCOTT, MD

Arch Ophthalmol. 1963;70(6):775-778.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Thioridazine (Mellaril) has been advertised as one of the safest tranquilizers. Nevertheless, nine cases of retinal pigmentation following its use have been reported.^1-8 The clinical picture is distinctive and closely resembles that seen following the use of another phenothiazine tranquilizer, NP-207. To further characterize the nature of this unusual side effect, the following case is reported.

Report of Case

A 19-year-old male college student developed symptoms of agitation and was admitted for treatment with a diagnosis of schizophrenia. He was first given chlorpromazine, but this was discontinued after one week when a rash developed. He then received 50 gm of thioridazine during a three-month period, with good psychic response. The daily dosage averaged 550 mg. No visual symptoms were noted.

Nine months later, he was readmitted with manic symptoms and placed on large doses of thioridazine. As shown in Fig 1, during a period of 60 days he received . . . [Full Text PDF of this Article]

Author Affiliations
Boston

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, 7 Bay State Road.

Footnotes
Submitted for publication May 9, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?